Bank Of New York Mellon Corp Forma Therapeutics Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $153,905 - $437,507	21,616 Added 20.79%	125,574 $2.51 Million
Q2 2022 Aug 15, 2022	SELL	$5.1 - $10.0 $57,793 - $113,320	-11,332 Reduced 9.83%	103,958 $716,000
Q1 2022 May 11, 2022	SELL	$8.34 - $14.69 $7,714 - $13,588	-925 Reduced 0.8%	115,290 $1.07 Million
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $43,207 - $79,075	3,177 Added 2.81%	116,215 $1.65 Million
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $326,215 - $395,086	15,373 Added 15.74%	113,038 $2.62 Million
Q2 2021 Aug 11, 2021	BUY	$22.86 - $30.95 $215,752 - $292,106	9,438 Added 10.7%	97,665 $2.43 Million
Q1 2021 May 13, 2021	BUY	$24.58 - $42.82 $667,912 - $1.16 Million	27,173 Added 44.51%	88,227 $2.47 Million
Q4 2020 Feb 09, 2021	BUY	$34.9 - $51.08 $518,614 - $759,048	14,860 Added 32.17%	61,054 $2.13 Million
Q3 2020 Nov 12, 2020	BUY	$32.95 - $50.25 $1.52 Million - $2.32 Million	46,194 New	46,194 $2.3 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.